Data 24/7

The only provider of continuous
glucose monitors (CGMs) that give 
patients and their followers continuous
readings every five minutes, every day.

Dexcom G6 is
Now Available for
Medicare Patients*

Get your patients started
quickly and conveniently
through retail pharmacy.

*See eligibility criteria here.

Coming in 2020:
Dexcom G6 Pro

Healthcare professionals will soon
be able to order the Dexcom G6 Pro
Continuous Glucose Monitoring (CGM)
System for their clinics.

Find Local
Coverage for
Dexcom G6

Use our new online search tool to
quickly find coverage on the plans
your patients use most often.

Dexcom CGM

A retail pharmacy prescription can be 
the fastest and easiest way to start
your patients on a Dexcom Continuous
Glucose Monitor (CGM).*

*Participating pharmacies may vary by state.


The smart iCGM solution for your
insulin-using patients.


Doctor Testimonials
See All Videos

Dexcom G6 Real-time CGM
Dexcom G6 CGM is now available for Medicare-eligible patients
Dexcom G6 Pro Coming in 2020
Dexcom G6 Pharmacy Coverage Is Available
Prescribe Dexcom CGM Today
Powerful. Proven. Protective. Dexcom

Protective Features


Dexcom G6 features an overall MARD of 9.0.1


Real-time continuous glucose readings are sent straight to your patient's smart device* or receiver every five minutes.

More Followers

Real-time glucose data can be shared with up to ten followers, increasing a patient's circle of support. Separate Follow App required.

Indicated for 2 Years
and Older

Dexcom is the only provider of CGM systems indicated for children ages 2 years and older.

Customizable Alerts

Two customized alert schedules can be set within a 24-hour period, giving patients more peace of mind and discretion, for example, while they are sleeping, exercising, or in a business meeting.

Urgent Low
Soon Alert

The Urgent Low Soon Alert can warn patients in advance of a potential severe hypoglycemic event (55 mg/dL or below)—allowing them time to take appropriate action before it happens.2


Proven Outcomes

Review the novel DIAMOND Study, as well as other clinical evidence
and professional society guidelines demonstrating the
benefits of Dexcom Continuous Glucose Monitoring (CGM).

Powerful Stories

Dr. Anita Swamy | Endocrinologist

Providers play a vital role in diabetes treatment, education, training and access to care for millions of Americans. Dexcom remains committed to helping empower providers with the best technology and resources for diabetes management. Hear why Endocrinologist Dr. Anita Swamy believes in Dexcom G6.

Dr. Swamy is a paid spokesperson of Dexcom, Inc.

See Story      See all Spotlights


Dexcom News & Events

Oct 8 2019

Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM

First and only single-use, professional CGM system with blinded or unblinded mode Dexcom, Inc. (NASDAQ:DXCM) announced today the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System for ...

*For a list of compatible devices, please visit
MARD is a statistical measure of accuracy.
1Dexcom G6 CGM System User Guide, 2018.
2Puhr S, Derdzinski M, Welsh JB, Parker AS, Walker T, Price DA. Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert. Diabetes Technol Ther. 2019; 21(4):155-158.
3Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: The DIAMOND randomized clinical trial. JAMA. 2017; 317(4); 371-378.

Contact Dexcom

If you are a clinician and want to learn more about Dexcom’s Continuous Glucose Monitoring Systems, please fill out the form and a Dexcom representative will contact you.

If you are a Dexcom User or Patient, please contact Dexcom here.

The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.